SUMMARY Bacterial counts were carried out on the faeces of 160 patients receiving clindamycin or lincomycin treatment for bacterial infections. In all the patients the total bacteroides count was significantly reduced while strains of Enterobacteriaciae, yeasts, and streptococci were correspondingly increased. Severe 
The clinical use of many antibiotics is associated with changes in gastrointestinal function in some patients. The incidence varies with the particular antibiotic, and the nature may range from a slight increase in bowel movements or less consistency of the faeces to severe watery diarrhoea with blood and mucus and possibly pseudomembranous colitis. The cause of the gastrointestinal dysfunction is not clear. Many explanations such as a direct toxic effect of the antibiotic or its metabolites; the overgrowth of certain pathogenic organisms such as Staphylococcus aureus, Candida albicans, and Pseudomonas aeruginosa; viruses; and toxins have been put forward. While quantitative studies have been carried out in normal patients there is little information about changes in the faecal flora of patients with diarrhoea or colitis.
In 1974 a prospective study of all patients in the High Wycombe group of hospitals receiving clindamycin or lincomycin was started and quantitative bacterial counts were carried out on the faeces of 160 patients. This paper describes the results and compares the changes with the development of gastrointestinal side effects.
Patients and methods
Specimens of faeces were collected from 160 A sample of faeces weighing about 1 g was disintegrated in 5 ml nutrient broth, serial hundredfold dilutions (0-1 ml in 9-9 ml) were made in nutrient broth, and surface viable counts using 0-1 ml inocula were carried out on blood, MacConkey, and a special yeast agar incubated aerobically and blood and neomycin blood agar (0-1 g/l) incubated anaerobically by the Gaspak method. The (Leigh et al., 1976) . Changes in the faecal bacterial counts were related to these normal findings and were considered significant when there was a decrease of 106 or more organisms in the expected bacteroides count, and an increase in the counts of Enterobacteriaciae (1(06 or more), streptococci (105 or more), and yeast (103 or more). Smaller changes in the bacterial counts were not considered significant in view of the techniques used.
Results
There was a significant decrease in the bacterioides count in all faecal specimens (Table 1 ) and in 95% D. A. Leigh and K. Simmons of cases this was lower than 5 x 103 organisms per gram of faeces. In patients receiving lincomycin streptococci were not increased in numbers as they were in patients receiving clindamycin. Otherwise both antibiotics produced similar changes, which were independent of the route of administration of the antibiotics. There was no difference between men and women in the faecal flora changes and the use of combined antibiotic therapy did not influence the findings.
Antibiotic-induced diarrhoea was seen in 25 (16%) of patients and 87 (57%) patients had mild gastrointestinal dysfunction related to surgery. The relationship of side effects to changes in flora are shown in Table 2 . There were no differences between the groups of patients apart from a higher incidence of increased yeast count when antibioticinduced diarrhoea was present. Although severe diarrhoea was nearly twice as common in patients who received prophylactic clindamycin or lincomycin ( Marr et al. (1975) reported that the anaerobic flora was only slightly reduced quantitatively in patients with diarrhoea receiving clindamycin but when pseudomembranous colitis was present the reduction was striking. However, in all our patients there was a considerable effect on the bacteroides count irrespective of the presence of diarrhoea. Metronidazole, another chemotherapeutic agent active against anaerobic bacteria, also causes a significant but lesser reduction in the number of bacteroides.
The role of Candida and other yeasts in the causation of diarrhoea is vague since there are increased numbers in the faeces with all antibiotic treatments and the prescription of antifungal treatment does not affect the incidence of diarrhoea. An increase in the numbers of strains of Enterobacteriaciae was common and, as seen with ampicillin (Leigh et al., 1976) , there was no relation to diarrhoea.
The problems of relating faecal flora to symptoms and side effects are complex. Besides the difficulties of collection and laboratory culture, the flora is in a dynamic state and is probably constantly changing. The relationship of the specimen to the last dose or the route of administration may significantly alter the bacteriology and the condition of the patient may considerably affect the pharmacology of the antibiotic. However, in a study using amoxycillin, ampicillin, and talampicillin consecutive faecal samples showed similar results and the normal quantitative flora was restored after treatment was stopped (Leigh, unpublished) .
The incidence of diarrhoea (16%) with clindamycin and lincomycin in our patients was similar to that found by Tedesco et al. (1974) , but no cases of pseudomembranous colitis were seen in our 160 patients or in those in a longer follow-up study (Leigh et al., 1977) . Possibly many of the reported cases of pseudomembranous colitis follow the irrational use of clindamycin and lincomycin for respiratory infections. The susceptibility of the patient is different when a severe anaerobic infection is present. Strikingly, Bartlett et al. (1972) , Fass et al. (1973) , Gorbach and Thadephalli (1974) , and Chow et al. (1974) using clindamycin and lincomycin in severe anaerobic infections have reported few cases of diarrhoea and no instances of pseudomembranous colitis.
Although changes in faecal flora could not be related to side effects there was a definite correlation between clindamycin and lincomycin and gastrointestinal side effects in respect of sex and age in our patients, women aged over 60 years being more likely to be affected. This confirms the findings of Swartzberg et al. (1976) and Smart et al. (1976) . It is still uncertain why most patients receiving clindamycin develop diarrhoea and why some of them progress to pseudomembranous colitis. Larson et al. (1977) have reported an undescribed cytotoxin in a patient who developed pseudomembranous colitis after penicillin therapy. This condition has also occurred with many other antibiotics-ampicillin (Keating et al., 1974) , amoxycillin (Simila et al., 1976) , chloramphenicol (Reiner et al., 1952) , tetracycline (Klotz et al., 1953) , cephalosporins (Tures et al., 1976) , and co-trimoxazole (Cameron and Thomas, 1977) . There have been reports of pseudomembranous colitis following lincomycin (Scott et al., 1973; Viteri et al., 1974) and clindamycin (Cohen et al., 1973; Tedesco et al., 1974) , but although the term clindamycin-associated colitis is in constant use this condition probably cannot be directly related to any particular compound.
The aetiology of pseudomembranous colitis is not clear and its development seems to be unrelated to the clinical condition of the patient or any one factor. The histology of tissue from patients with pseudomembranous colitis suggests various causesa local Swartzman phenomenon (Hjort and Rapaport, 1965), ischaemia (McGovern and Goulston, 1965) , or capillary thrombosis (Whitehead, 1971; Bogomoletz. 1976) . But as these changes are not seen in all stages of the condition it seems more likely that they follow an initiating factor, since D. A. Leigh and K. Simmoni idiopathic pseudomembranous colitis is rarely reported (Jackson and Anders, 1972 ) and geographical differences have been suggested by Geddes (1974) . A viral or bacterial aetiology has been reported (Steer, 1975; Marr et al., 1976) , but there is little indication that an altered faecal flora in terms of the normal bacteria or usual pathogens plays a major role.
The possibility of genetic influence is interesting and cannot be excluded (Harrod et al., 1975) . The increased incidence of diarrhoea among patients receiving lincomycin and atropine-diphenoxylate (Lomotil) or codein phosphate (Novak et al., 1976) suggests that decreased intestinal motility may increase the contact time between the antibiotic and its metabolites and the intestinal mucosa, allowing a toxic reaction to occur. However, decreased intestinal motility is common after gastrointestinal surgery, and few reports of pseudomembranous colitis are seen in these patients. Probably the initiating factor is a toxic agent acting directly on the intestinal mucosa (Pittman et al., 1974) leading to a two-stage process of a local Schwartzman phenomenon and capillary microthrombi , but its nature is unknown. Although the true incidence of pseudomembranous colitis is not well documented, and its frequency is overemphasised by the large number of single cases reported, a common association in its development is antibiotic therapy. Since which patients will develop the complication cannot be predicted chemotherapy must be used carefully, especially for prophylaxis. 
